A B S T R A C T The effect of gastrin on basal-and glucose-stimulated insulin secretion was studied in 32 normal, young subjects. The concentration of gastrin and insulin in serum was measured radioimmunochemically.
INTRODUCTION
Gastrointestinal hormones probably contribute significantly to the stimulation of insulin secretion during ingestion of glucose or protein (1) (2) (3) (4) . It has been suggested that more than half the insulin response to oral intake of glucose is caused by enteric hormones (5) . At the present time there is a considerable debate as to which hormone or hormones mediate the insulin response.
Concerning the action of gastrin on insulin secretion, stimulation (6-11), no effect (12) (13) (14) (15) (16) , as well as inhibition (17) have been reported. The conflicting results may in part be due to the use of pharmacological doses of crude preparations or fragments of gastrin. However, radioimmunoassay techniques for gastrin are now at hand (18) (19) (20) (21) , and hence the physiologic action of gastrin can be assessed.
In the present study the effect of endogenous and exogenous human gastrin on basal-and glucose-stimulated insulin secretion in man has been investigated and monitored by means of reliable radioimmunoassays for human gastrin and insulin. METHODS
Experimental procedures
32 normal nonobese subjects, 24 males and 8 females, all members of the paramedical staff and aged from 24 to 42 yr participated in the study. They all had normal oral and i.v. glucose tolerance tests, and none had close relatives with diabetes mellitus. Informed consent was obtained from each subject.
The subjects were on a diet containing at least 250 g carbohydrates per day 3 days before each investigation.
steak, sauce, vegetables, and a glass of water (22) . The subjects were told to eat as much as they liked, and the meal was finished after 20 min. Blood samples were drawn 15, 10, and 5 min before, and 2, 5, 10, 20, 30, 45, 60, 90, and 120 min after the onset of the meal. Oral glucose loading. 20 subjects, 5 females and 15 males, were given 50 g of oral glucose in a 25% solution, flavored with lemon. Blood samples were drawn 15, 10, and 5 min before the loading, and 5, 10 ,15, 20, 30, 40, 50, 60 90, 120, 150 , and 180 min after.
Intravenous glucose infusions. 1 wk after the oral load the 20 subjects were submitted to an i.v. glucose infusion designed to copy the changes in blood glucose concentrations found during the oral load. 16i g glucose in concentrations from 33 to 50% were given at a constant flow rate by an infusion pump in an antecubital vein. Blood samples were drawn from the opposite arm at intervals identical with those in the oral glucose test.
Studies on the effect of exogenous gastrin on insulin secretion
Intravenous infusion of gastrin. In five subjects, one female and four males, synthetic human gastrin I (SHG I from Imperial Chemical Industries, Cheshire, England) ' was given i.v. as a rapid injection of 62.5 ng per kg body weight followed by 30 min infusion of 12. before, and 0, 2, 5, 10, 20, 30, 
Laboratory methods
Serum gastrin concentrations were measured with a radioimmunoassay (21) using a purified monoiodinated gastrin preparation (23) . The antisera used (2604 and 2609) were produced in rabbits against synthetic hexadecapeptide gastrin (2-17) covalently coupled by carbodiimide to bovine serum albumin (24) . The binding energy, expressed by the average equilibrium constant, was 1.1 X 10 (2604) and 4.4 X 1010 liters/mol (2609). The detection limit of the assays was < 20 fmol gastrin per liter (2604) and < 2 pmol per liter incubation mixture (2609). The working range of the assay was 2-140 (2604) and 100-5,000 pmol per liter (2609). Antiserum 2604 was used to measure physiologic concentrations of gastrin in serum, whereas antiserum 2609 was reserved for sera with high concentrations of gastrin (Fig. 1) . The specificity of the assay was expressed by the molar ratio between the inhibition dose 50 for SHG and highly purified cholecystokinin. For antiserum 2604 the ratio was 0.006, and for antiserum 2609 it was 0.002. No other known hormone cross-reacted with the antisera. Within-assay precision was tested by 10 determinations of two serum samples. Mean-gastrin concentration ± 1 SD was 84.4±3.9 pmol per liter and 13.4±4.8 pmol per liter respectively. Between-assay reproducibility was tested during 21 assays covering a period of 4 mo; for three sera the mean and standard deviations were 24.0±0.8, 8 .1+1.8, and 43.4±3.0 pmol per liter. The relative accuracy was estimated by comparison of reference concentrations with those reported by other groups. In our laboratories the mean concentration of gastrin in serum from healthy, fasting subjects was found to be 23.6+2.1 pmol per liter or 52.0±4.6 pg eq SHG per ml (±SEM, n = 120). These concentrations are of the same order as those reported by others (18) (19) (20) 25) . Superimposable dose-response curves were obtained with synthetic human gastrin in serum-freed of gastrin, and with serial dilutions of sera. Measurements of gastrin concentrations in sera with added exogenous gastrin, in dilutions of sera, and in mixtures of sera with different concentrations yielded results, which deviated less than 10%o from the expected values.
Serum insulin concentrations were measured by means of a wick-chromatographic radioimmunoassay (26) . The working range of the assay was 35-1,400 pmol per liter with a detection limit < Gastric acid was measured by titration with 0.2 N sodium hydroxide to pH 7.0, employing an Autotitrator (Radiometer, Copenhagen, Denmark).
Calculations. The integrated insulin response and integrated gastrin stimulus were computed as the area under the serum insulin and serum gastrin curves in the time intervals indicated using fasting levels as base line. The glucose disappearance rate was calculated as K = In 2/t! X 100 from the studies with i.v. glucose administration. The significance of differences between means was tested by Student's t test. The concentrations of blood glucose, serum insulin, and serum gastrin are given as mean ±SEM in molar units. Concentration units used by others, e.g., mg/ 100 ml, ;sU/ml, and pg/ml, are indicated in brackets in the text.
In the tables conventional units are used.
RESULTS

Studies on endogenous gastrin
Response to a protein-rich meal (Fig. 2 ). Blood glucose. oncentratjions showed an initial small' decrease from 3.85±0.15 (69.3±2.7 mg per 100 ml) to 3.76±0.15 mmol per liter (67.7+2.7 mg per 100 ml). The peak concentration of 4.74±0.42 mmol per liter (85.3±+7.6 mg per 100 ml), was observed after 45 min.
The increase in serum insulin concentration appeared later than the increase in gastrin concentrations. The (Fig. 3) . Variations in blood glucose and serum insulin concentrations are givern in the figure. The basal gastrin concentration of 28.0±3.5 pmol per liter (61.6±7.7 pg eq SHG per ml) rose in 5 min to 39.0±5.6 pmol per liter (85.8±12.3 pg eq SHG per ml), and was followed by a slow decrease. The maximum concentrations differed from the fasting levels (P < 0.01).
Response to intravenous glucose infusion (Fig. 3) . The glucose infusion produced variations in mean glucose concentrations in the blood almost similar to the ones observed during the oral glucose tolerance test.
The increase in insulin concentrations was less than during the oral glucose loading and the difference was highly significant.
No significant changes in serum gastrin concentrations were found. There was, however, a tendency to- 
I
Response to intravenous gastrin injections ( Fig. 5 and Table I ). The blood glucose concentration was elevated after gastrin injections. The rapid injection of gastrin caused an immediate insulin release with maximum concentration in peripheral venous serum after 2 min. Insulin concentrations returned to basal levels within 10 min at a time, when the concentration of gastrin was still about 20 times above fasting levels. After 20 min a slight increase in insulin concentrations was found.
The immediate insulin response to gastrin lasted less than 20 min for all doses of gastrin (Table I) .
The insulin response to glucose was as rapid as the one to gastrin, and in one subject it reached similar levels. The glucose-induced response was, however, considerably more sustained (Fig. 5) .
The dose-response interrelationship (Fig. 6 BG, blood glucose (mg/100 ml); SI, serum insulin (microunits per milliliter); and SG, serum gastrin (picograms per milliliter). maximum concentration observed during a protein-rich meal (Fig. 2) .
Response to simultaneous intravenous injection of gastrin and glucose (Fig. 7 (Fig. 7) . The integrated insulin responses to increasing doses of gastrin with and without glucose are compared in Table II. Effect of gastrin on glucose disappearance rate (Table  IV) . The glucose disappearance rate after i.v. glucose administration was not changed by the addition of increasing doses of gastrin.
Response to intravenous glucose after prior administration of gastrin ( Fig. 8 (Fig.  2) . It hence appears that gastrin might be an insulin stimulator, probably in connection with other gut hormones and amino acids. A protein-rich meal is considered to be one of the strongest physiologic stimuli for gastrin secretion, and assessed from this stimulus the maximum physiologic gastrin concentrations in serum are in the order of 160 pmol per liter (350 pg eq SHG per ml).
That an insulinotropic action of gut hormones may exist was originally suggested by the difference in insulin response observed after oral and i.v. glucose administration (1-3) . In the present investigation the glycemic stimulus was of the same magnitude whether glucose was administered parenterally or orally. Hence the apparent difference in insulin response may be taken as a measure of the effect of the gut hormones. The size of the enteral hormonal stimulation was about two-thirds of the total insulin response to oral glucose, in accordance with the results of Perley and Kipnis (5). Since only moderate amounts of gastrin were released by ingestion of oral glucose, gastrin is probably not a major insulin secretagogue during an oral glucose loading.
The nature of the insulin response to exogenous gastrin was apparently independent of whether gastrin was administered as a rapid i.v. injection (Fig. 5) or as a 30 min infusion (Fig. 4) (32) , and possibly (b) by an indirect effect mediated through activation of other gastrointestinal hormones released by acid in duodenum and jejunum. The magnitude and steepness in the increase of gastrin concentrations seem to govern the insulin response rather than the total integrated gastrin stimulus. The dose-response studies of the effect on basal insulin secretion showed that the gastrin doses required for a significant insulin response resulted in unphysiologic concentrations of gastrin in serum. In contrast the glucose-stimulated insulin secretion was significantly potentiated by small doses of gastrin, resulting in serum gastrin levels within physiologic limits. The effect was not additive, but obviously potentiating and direct since the increase in the glucose-mediated insulin release was observed in the 1st min ( Fig. 5 and Table III ). It is notable that the gastrin-potentiated insulin increase did not influence the glucose disappearance rate (Table IV) 
